Session Details
Poster Session(I-P03-2)
Acute KD treatment
Thu. Jul 10, 2025 4:10 PM - 5:10 PM JST
Thu. Jul 10, 2025 7:10 AM - 8:10 AM UTC
Thu. Jul 10, 2025 7:10 AM - 8:10 AM UTC
Poster Venue (Fine Arts Center, 2F Gallery 1 and 2)
Chair:Kazuyoshi Saito(Department of Pediatrics, School of Medicine, Fujita Helath University, Aichi, Japan)
Mitsuru Seki(Department of Pediatrics, Jichi Medical University, Tochigi, Japan)
Mitsuru Seki(Department of Pediatrics, Jichi Medical University, Tochigi, Japan)
[I-P03-2-01]Utility of Complete Blood Count-Derived Inflammatory Markers for Predicting IVIG Resistance in Infant Kawasaki Disease
○Young Tae Lim (Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Republic of Korea)
[I-P03-2-02]Cluster Analysis of Kawasaki Disease Patients with Coronary Artery Abnormalities - Identification of Subgroups with Distinct Characteristics-
○Yuto Sunaga, Yohei Hasebe, Natsumi Kikuchi, Masashi Yoshizawa, Yosuke Kono, Nobuyuki Katsumata, Takeshi Inukai (Department of Pediatrics, Faculty of Medicine, University of Yamanashi)
[I-P03-2-03]Exploring Viral Infections' Role in Kawasaki Disease Onset: A Study duringthe COVID-19 Pandemic
○Taku Ishii1, Yohei Yamaguchi1, Makito Saurai1, Teruyoshi Shimoyama1, Susumu Hosokawa2 (1.Department of Pediatrics, Institute of Science Tokyo, Tokyo, Japan, 2.Department of Pediatrics, Japanese Red Cross Musashino Hospital, Tokyo, Japan)
[I-P03-2-04]Diagnostic impact of the mid-coronary arterial wall echogenicity in the initial diagnosis of Kawasaki Disease
○Naoto Yamashita, Hirofumi Irisa, Toshinobu Ifuku (Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital)
[I-P03-2-05]Treatment reactivity and coronary artery outcome in case of Kawasaki disease with coronary artery lesions before treatment
○Kazuyuki Ikeda, Yusuke Kita, Satoshi Inoue, Yoko Kawai, Yo Kajiyama (Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)
[I-P03-2-06]Usefulness of initial IVIG with short-term Prednisolone and additional IVIG with IVMP for refractory Kawasaki Disease
○Hideki Fujita, Aya Kondo, Kazuya Uemura (The department of Pediatric Cardiology)
[I-P03-2-07]A Comparison of IVIG plus prednisolone therapy with conventional therapy in patients with Kawasaki disease other than therapeutic benefit
○Kaori Ueno1, Ken Watanabe2, Fumitoshi Tsurumi1 (1.Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, 2.Takabatake Women's Clinic)
[I-P03-2-08]Impact of recent additional treatments in the acute phase of Kawasaki disease on the prevention of coronary artery lesions at our hospital
○Sachiko Inukai, Ryouta Yamazaki (Department of Pediatrics, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan)
[I-P03-2-09]Treatment strategies for Refractory Kawasaki Disease in infants-Plasma Exchange or Infliximab-
○Hirohito Doi1,2, Takashi Kumamoto1 (1.The Department of Pediatrics, University of Saga, Saga, Japan, 2.The Department of Pediatrics, NHO Ureshino Medical Center, Saga, Japan)
[I-P03-2-10]Efficacy of Combined Plasma Exchange and Methylprednisolone Pulse Therapy for Refractory Kawasaki Disease
○Shinsuke Hoshino, Takafumi iguchi, masami fujita, ouki furukawa (Shiga University of Medical Science)